Chaisson RE - Search Results

1

Functional status of persons with HIV infection in an ambulatory setting.

Stanton DL, Wu AW, Moore RD, Rucker SC, Piazza MP, Abrams JE, Chaisson RE. Stanton DL, et al. Among authors: chaisson re. J Acquir Immune Defic Syndr (1988). 1994 Oct;7(10):1050-6. J Acquir Immune Defic Syndr (1988). 1994. PMID: 8083822

2

Impact of the 1993 revision of the AIDS case definition on the prevalence of AIDS in a clinical setting.

Chaisson RE, Stanton DL, Gallant JE, Rucker S, Bartlett JG, Moore RD. Chaisson RE, et al. AIDS. 1993 Jun;7(6):857-62. doi: 10.1097/00002030-199306000-00015. AIDS. 1993. PMID: 8103343

3

Zidovudine therapy and health resource utilization in AIDS.

Moore RD, Hidalgo J, Bareta JC, Chaisson RE. Moore RD, et al. Among authors: chaisson re. J Acquir Immune Defic Syndr (1988). 1994 Apr;7(4):349-54. J Acquir Immune Defic Syndr (1988). 1994. PMID: 8133446

4

Effects of an incentive and education program on return rates for PPD test reading in patients with HIV infection.

Chaisson RE, Keruly JC, McAvinue S, Gallant JE, Moore RD. Chaisson RE, et al. J Acquir Immune Defic Syndr Hum Retrovirol. 1996 Apr 15;11(5):455-9. doi: 10.1097/00042560-199604150-00005. J Acquir Immune Defic Syndr Hum Retrovirol. 1996. PMID: 8605590

5

Natural history of opportunistic disease in an HIV-infected urban clinical cohort.

Moore RD, Chaisson RE. Moore RD, et al. Among authors: chaisson re. Ann Intern Med. 1996 Apr 1;124(7):633-42. doi: 10.7326/0003-4819-124-7-199604010-00003. Ann Intern Med. 1996. PMID: 8607591

6

Duration of the survival benefit of zidovudine therapy in HIV infection.

Moore RD, Keruly JC, Chaisson RE. Moore RD, et al. Among authors: chaisson re. Arch Intern Med. 1996 May 27;156(10):1073-7. Arch Intern Med. 1996. PMID: 8638994

7

Costs to Medicaid of advancing immunosuppression in an urban HIV-infected patient population in Maryland.

Moore RD, Chaisson RE. Moore RD, et al. Among authors: chaisson re. J Acquir Immune Defic Syndr Hum Retrovirol. 1997 Mar 1;14(3):223-31. doi: 10.1097/00042560-199703010-00005. J Acquir Immune Defic Syndr Hum Retrovirol. 1997. PMID: 9117454

8

Prevention of opportunistic infections in the era of improved antiretroviral therapy.

Chaisson RE, Moore RD. Chaisson RE, et al. J Acquir Immune Defic Syndr Hum Retrovirol. 1997;16 Suppl 1:S14-22. doi: 10.1097/00042560-199701001-00003. J Acquir Immune Defic Syndr Hum Retrovirol. 1997. PMID: 9389311 Review.

9

Impact of opportunistic disease on survival in patients with HIV infection.

Chaisson RE, Gallant JE, Keruly JC, Moore RD. Chaisson RE, et al. AIDS. 1998 Jan 1;12(1):29-33. doi: 10.1097/00002030-199801000-00004. AIDS. 1998. PMID: 9456252

10

Adherence to antiretroviral and pneumocystis prophylaxis in HIV disease.

Eldred LJ, Wu AW, Chaisson RE, Moore RD. Eldred LJ, et al. Among authors: chaisson re. J Acquir Immune Defic Syndr Hum Retrovirol. 1998 Jun 1;18(2):117-25. doi: 10.1097/00042560-199806010-00003. J Acquir Immune Defic Syndr Hum Retrovirol. 1998. PMID: 9637576

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

457 results

Search Page

Filters